JPRN-UMIN000001011Unknown未知
The efficacy and safety of 2.5% testosterone gel for late-onset hypogonadsism patients evaluated by using salivary testosterone. - The efficacy of 2.5% testosterone gel for late-onset hypogonadsism patients
Teikyo University, School of Medicine0 sites15 target enrollmentStarted: February 10, 2008Last updated:
Trial Snapshot
- Phase
- 未知
- Sponsor
- Enrollment
- 15
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 40years-old to 90years-old (—)
- Sex
- Male
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients having serious heart, iver, and renal dysfunction. Pasients who have serious pshychiatric problems are also excluded.
Investigators
Similar Trials
Completed
Phase 4
The efficacy of testosterone gel application for increases the sperm concentration in infertile men with oligospermia and low serum testosterone levelTCTR20161030001Faculty of Medicine, Siriraj Hospital16
Completed
Phase 4
The effects of testosterone gel administration in ARTinfertility.Female infertility associated with anovulationIRCT201505197513N11Isfahan University of Medical Sciences64
Active, not recruiting
Not Applicable
Endocrine study on the effects of testosterone gel application in male athletesThere will not be any special medical condition under investigation.Only healthy volunteers will be included in this clinical trial.EUCTR2005-001453-22-DEGerman Sport University Cologne, Institute of CArdiology and Sports Medicine16
Completed
Phase 2
The effect of transdermal testosterone gel300mcg daily on cognitive performance in older postmenopausal women: a placebo controlled trial over 26 weekscognition in older postmenopausal womenMental Health - Studies of normal psychology, cognitive function and behaviourACTRN12609000981224Monash University120
Recruiting
Phase 3
The efficacy and safety of 0.5% topical timolol on corneometry and transepidermal water loss after ablative fractional CO2 laser for atrophic acne scars: a split face randomized double blind placebo-controlled trialWe considered that timolol may have an effect in wound healing promotion in patients who undergo AFCO2 resurfacing. Our study aimed to investigate the efficacy and safety of 0.5% topical timolol maleaTCTR20190722005none25